Stanpack Pharma Private Limited
About Stanpack Pharma Private Limited
Data last updated:
Stanpack Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 March 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1994PTC077217. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Sanjay Kumar Prasad (Managing Director) and Archana Sanjay Prasad.
Its last annual general meeting (AGM) was held on 30 November 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 201 Plot No. 100 Sunrise Arcade Sector 16 Kopar Khairane Navi Mumbai, Maharashtra, India – 400709.
As per the financials filed for FY 2018, the company reported a revenue of ₹9.41 Lakh, a growth of 101% compared to the previous year. For the same year it recorded a net profit of ₹1.88 Lakh (net margin 20%) and EBITDA of ₹2.38 Lakh (EBITDA margin 25.3%).
As per MCA filings, the company has open charges of ₹1.84 Cr and satisfied charges of ₹23.88 Cr on record. Court records list 70 cases involving the company, including 19 filed by the company and 47 filed against it; 13 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address201 Plot No. 100 Sunrise Arcade Sector 16 Kopar Khairane Navi Mumbai, Maharashtra, India – 400709
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Stanpack Pharma Private Limited FY 2024 filings available
Stanpack Pharma Private Limited reported revenue of ₹9.41 Lakh (up 101% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR) of Stanpack Pharma Private Limited
Revenue rose 101% in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stanpack Pharma Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | ₹9.41 Lakh | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.38 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.88 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Stanpack Pharma Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 25.3% | •••• | •••• | •••• |
| Net Profit Margin | 20% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stanpack Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Stanpack Pharma Private Limited
Stanpack Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ascent Innovative Medicines Private Limited | ₹9.56 Lakh (FY 2025) | •••• | •••• | -83.0% | •••• | Mumbai, Maharashtra, India |
| V23 Medical Solutions Private Limited | ₹9.52 Lakh (FY 2024) | •••• | •••• | 8.0% | •••• | Hyderabad, Telangana, India |
| Navlok Healthcare Private Limited | ₹9.5 Lakh (FY 2025) | •••• | •••• | •••• | Begusarai, Bihar, India | |
| Brightway Pharmaceuticals Private Limited | ₹9.49 Lakh (FY 2022) | •••• | •••• | 524.0% | •••• | Solapur, Maharashtra, India |
| Takimo Pharma Private Limited | ₹9.42 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Kakinada, Andhra Pradesh, India |
| Stanpack Pharma Private Limited this company | ₹9.41 Lakh (FY 2018) | •••• | •••• | 101.0% | •••• | Navi Mumbai, Maharashtra, India |
| Welcure Drugs and Pharmaceuticals Limited Listed | ₹9.4 Lakh (FY 2024) | •••• | •••• | -60.0% | •••• | New Delhi, Delhi, India |
| HRG Health Care Private Limited | ₹9.38 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Kolkata, West Bengal, India |
| Omprabhu Granites Private Limited | ₹9.36 Lakh (FY 2024) | •••• | •••• | 88.0% | •••• | Lucknow, Uttar Pradesh, India |
| Shalaks Pharmaceuticals Pvt Ltd | ₹9.33 Lakh (FY 2024) | •••• | •••• | -35.0% | •••• | New Delhi, Delhi, India |
| Acuist Pharmaceuticals (India) Private Limited | ₹9.32 Lakh (FY 2023) | •••• | •••• | 666.0% | •••• | Gandhidham, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Stanpack Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Stanpack Pharma Private Limited
Stanpack Pharma Private Limited is audited by K F JETSEY & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K F JETSEY & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Stanpack Pharma Private Limited
Stanpack Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Sanjay Prasad | Director | 01 Apr 2009 | 17 Years 6 Months | Current |
| Sanjay Kumar Prasad | Managing Director | 22 Mar 1994 | 32 Years 6 Months | Current |
Ownership and Shareholding of Stanpack Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Stanpack Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2008 | Tifac | ₹1.84 Cr | Open |
| 14 Mar 2011 | Union Bank of India | ₹3.85 Cr | Satisfied |
| 04 Jun 2007 | Union Bank of India | ₹1 Cr | Satisfied |
| 04 Jun 2007 | Union Bank of India | ₹7.96 Cr | Satisfied |
| 04 Jun 2007 | Union Bank of India | ₹20 Lakh | Satisfied |
Total charge records: 12 View all charges
Legal Cases of Stanpack Pharma Private Limited
Stanpack Pharma Private Limited has 70 court cases on record: 19 filed by Stanpack Pharma, 47 filed against it, 4 where it is another party. 13 cases are pending and 57 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 69 | 47 | 12 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 70)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Secu. Case) | Filed against the company by Union Bank of India Limited | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR A) | Company is another party | Pending |
| District court, South, Delhi | Appeal | Filed by the company against Technology Information, Forecasting and Assessment Council (Tifac) | Pending |
| District court, South, Delhi | Appeal | Filed by the company against Technology Information, Forecasting and Assessment Council Tifac | Pending |
| High Court of Delhi | Revision petition | Filed by the company against Technology Information Forecasting Assessment Council- Tifac | Pending |
Full case history
All 70 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Stanpack Pharma Private Limited
Employment history and EPFO contributions of people linked to Stanpack Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stanpack Pharma Private Limited
Stanpack Pharma Private Limited has 3 board changes on record since 1994: 2 appointments and 1 cessation. The latest: Rajiv Suresh Priyadarshi ceased to be Managing Director on 01 May 2009.
20 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Stanpack Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stanpack Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stanpack Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stanpack Pharma Private Limited
Stanpack Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stanpack Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stanpack Pharma Private Limited
Stanpack Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 March 1994 (32+ years old) and is registered under CIN U24239MH1994PTC077217.
Stanpack Pharma reported revenue of ₹9.41 Lakh for FY 2018 (up 101% YoY).
Stanpack Pharma has 2 current directors:
- Sanjay Kumar Prasad - Managing Director
- Archana Sanjay Prasad - Director
Stanpack Pharma reported a net profit of ₹1.88 Lakh (net margin 20%) and EBITDA of ₹2.38 Lakh (EBITDA margin 25.3%) for FY 2018, as per its filed financial statements.
No. Stanpack Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Stanpack Pharma is U24239MH1994PTC077217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stanpack Pharma has 70 court cases on record: 19 filed by the company and 47 filed against it. 13 are pending. Most are in the district courts.
Stanpack Pharma was incorporated on 22 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Stanpack Pharma by revenue are Ascent Innovative Medicines Private Limited, V23 Medical Solutions Private Limited, Navlok Healthcare Private Limited, Brightway Pharmaceuticals Private Limited, Takimo Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Rajiv Suresh Priyadarshi ceased to be Managing Director on 01 May 2009. Archana Sanjay Prasad was appointed as Director on 01 Apr 2009. Sanjay Kumar Prasad was appointed as Managing Director on 22 Mar 1994.
The registered office of Stanpack Pharma is at 201 Plot No. 100 Sunrise Arcade Sector 16 Kopar Khairane Navi Mumbai, Maharashtra, India – 400709.